Sirona Dx
Business Services · Oregon, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4640 S Macadam Ave, Portland, Oregon, 97...Phone Number
(503) 919-8919Website
www.sironadx.comRevenue
<$5 MillionIndustry
About Sirona Dx
Sirona Dx is a technical Contract Research Organization (CRO) founded in 2016, specializing in accelerating the development of immunotherapy and targeted therapy through advanced single cell and spatial biology services. The company offers a range of services including bioinformatics, imaging mass cytometry, and immune profiling, aimed at supporting exploratory biomarker programs and precision medicine initiatives. With a focus on innovative technologies and deep technical expertise, Sirona Dx partners with life science companies to optimize assay design and accelerate therapies towards regulatory approval. Their unique approach includes providing early access to cutting-edge technologies within a CLIA accredited laboratory, ensuring compliance with pharma regulatory requirements.Explore more
SIC Code 87,873NAICS Code 54,541Show moreSirona Dx Org Chart
Compare Similar Companies to Sirona Dx
Compare insights from companies similar to Sirona Dx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sirona Dx Tech Stack
A closer look at the technologies used by Sirona Dx
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sirona Dx
Sign Up For FreeTo access detailed company insights
Sirona Dx is a technical Contract Research Organization (CRO) founded in 2016, specializing in accelerating the development of immunotherapy and targeted therapy through advanced single cell and spatial biology services. The company offers a range of services including bioinformatics, imaging mass cytometry, and immune profiling, aimed at supportin... Read More